Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z3ES
|
|||
| Former ID |
DIB009372
|
|||
| Drug Name |
Melanoma vaccine, University of Virginia
|
|||
| Synonyms |
Vaccine (melanoma); Melanoma-specific antigens, Argonex; Peptide vaccine/autologous dendritic cells, Argonex; Vaccine (melanoma), Argonex; Vaccine (melanoma), University of Virginia
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 3 | [1] | |
| Company |
University of Virginia
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01546571) Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.